In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1016070230538
Reference47 articles.
1. Aung TT, Davis MA, Ensminger WD, Lawrence TS: Interaction between gemcitabine and mitomycin-C in vitro. Cancer Chemother Pharmacol 45: 38–42, 2000
2. Budman D, Calabro A, Kreis W: In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents. Anti-Cancer Drugs 9: 687–702, 1998
3. Kalemkerian GP, Ou X: Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines. Cancer Chemother Pharmacol 43: 145–150, 1999
4. Li L, Keating MJ, Plunkett W, Yang LY: Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance. Mol Pharmacol 52: 798–806, 1997
5. Piras G, Nakade K, Yuasa S, Baba M: Three-drug combination of MKC-442, lamivudine and zidovudine in vitro: potential approach towards effective chemotherapy against HIV-1. Aids 11: 469–475, 1997
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting cuproplasia and cuproptosis in cancer;Nature Reviews Clinical Oncology;2024-03-14
2. Disulfiram in glioma: Literature review of drug repurposing;Frontiers in Pharmacology;2022-08-24
3. Potential cancer treatment effects of brusatol or eriodictyol combined with 5-fluorouracil (5-FU) in colorectal cancer cell;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-07-20
4. Copper-lowering agents as an adjuvant in chemotherapy;Indian Journal of Pharmacology;2021
5. Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer;Drug Delivery and Translational Research;2020-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3